RNA Epigenetics in Chronic Lung Diseases.

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Epigenetics

Background:

• Chronic lung diseases, including lung cancer, represent a significant global health burden.
• RNA epigenetics dynamically regulates gene expression and cellular functions, impacting disease development.
• Emerging evidence highlights the critical role of RNA modifications in the pathogenesis of chronic lung diseases.

Purpose of the Study:

• To review fundamental RNA modifications and their involvement in chronic lung diseases.
• To elucidate the mechanisms by which RNA epigenetics influences lung disease progression.
• To identify potential new biomarkers and therapeutic targets for chronic lung diseases.

Main Methods:

• Comprehensive literature review of RNA modifications and their association with lung diseases.
• Detailed examination of specific RNA modifications: m6A, m1A, m7G, m5C, Nm, Ψ, and A-to-I editing.
• Analysis of the functional roles of these modifications in the context of chronic lung disease pathogenesis.

Main Results:

• Multiple RNA modifications, including N6 methylation of adenosine (m6A) and adenosine to inosine RNA editing (A-to-I), are implicated in chronic lung diseases.
• These modifications influence gene expression, cellular processes, and disease progression in the lungs.
• The study details the specific roles of various RNA modifications in different types of lung disease.

Conclusions:

• RNA epigenetics offers promising avenues for understanding and combating chronic lung diseases.
• Further research into RNA modification mechanisms can facilitate the development of novel early diagnostic tools.
• Targeting RNA modifications presents a potential strategy for innovative therapeutic interventions in lung disease treatment.